Exhibit of Law Library Books to be Held in New York City
An exhibit, “Law’s Picture Books: The Yale Law Library Collection,” will be on display at New York City’s Grolier Club from September 13 to November 18, 2017.
Dean Gerken Files Amicus Brief in Partisan Gerrymandering Case
Dean and Sol & Lillian Goldman Professor of Law Heather Gerken has filed an amicus brief with the U.S. Supreme Court in Gill v. Whitford, a Wisconsin case that tests the constitutional boundaries of partisan gerrymandering.
Professor Silk to Give Binger Inaugural Lecture on October 16
Professor James Silk will deliver his inaugural lecture as the first Binger Clinical Professor of Human Rights on Monday, October 16, 2017 at 4:30 p.m. in Room 127.
Corporate Law Center Announces Fall Colloquium Schedule
The YLS Center for the Study of Corporate Law (ccl.yale.edu) has announced its Fall 2017 schedule for the Marvin A. Chirelstein Colloquium on Contemporary Issues in Law and Business.
SFALP Case Secures Court Victory Against Unlawful Diversion Program
After nearly two years, the San Francisco Affirmative Litigation Project (SFALP) recently won an important victory in court against the Corrective Education Company (CEC) over its diversion program to suspected shoplifters.
Solomon Center Submits Comments to HHS
A team of physician and attorney partners affiliated with the Solomon Center for Health Law & Policy at Yale Law School recently submitted comments to the U.S. Department of Health & Human Services Centers for Medicare and Medicaid Services.
Dean Gerken Welcomes Most Diverse Class in YLS History
The most diverse class in Yale Law School history arrived at the Sterling Law Building in New Haven on Monday, August 21, 2017, with 205 newly minted law students taking the first step in their legal careers.
MFIA/CRIT Lawsuit Prompts Expedited Release of Information from FDA
In response to a lawsuit filed by Yale Law School’s MFIA Clinic MFIA and supported by CRIT, the FDA granted expedited processing to a FOIA request for information concerning one of the most controversial drug approvals in FDA history and the contested clinical trials supporting it.